Key result
Diabetic neuropathies affect approximately 50% of people with diabetes, requiring early diagnosis and appropriate management through clinical evaluation and objective tests.
Why the study?
Diabetic neuropathy affects approximately 50% of people with diabetes, and early diagnosis and appropriate management are essential to alleviate disabling symptoms and improve quality of life.
This review outlines the clinical manifestations and objective tests for the early diagnosis and management of diabetic neuropathies.
Diabetes mellitus is a major health problem globally that increases the economic burden of every country. According to the International Diabetes Federation (IDF) in 2021, 1 in 10 adults are living with diabetes. About 352 million adults have uncontrolled glycemic profiles worldwide. Diabetes is likely to affect 552 million people worldwide by 2030. Diabetes and its complications are emerging as the leading cause of morbidity and mortality. Diabetes neuropathies are estimated to affect approximately 50% of people suffering with diabetes. Neuropathy, the most prevalent microvascular complication of diabetes mellitus, includes distal symmetric polyneuropathy, radiculoplexus neuropathy, autonomic neuropathy, mononeuropathy, and treatment-induced neuropathy. Early diagnosis and appropriate management of diabetic neuropathy are essential to alleviate disabling symptoms and to improve the quality of life of patients. This review discusses clinical manifestations and evaluation of diabetic neuropathies as well as appropriate objective tests helpful in diagnosing diabetic neuropathies.
No takes yet. Share an insight, caveat, or question.
Varma et al. (2022) conducted a review in Diabetic neuropathies. Diabetic neuropathies affect approximately 50% of people with diabetes, requiring early diagnosis and appropriate management through clinical evaluation and objective tests.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: